Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection

By Jian-hua Xia, J. Tong, Mengyun Liu, Ye Shen, Dongyu Guo. Journal of Medical Virology, 2020

1,058 citations recorded by the source corpus.

This study aimed to assess the presence of novel coronavirus in tears and conjunctival secretions of SARS–CoV‐2‐infected patients.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms (2020, positive): “The suspected patients with COVID-19 with GI symptoms, such as nausea, vomiting and diarrhoea, should be seriously considered, since accumulated evidence supports SARS-CoV-2 transmission through faeces 11 and tears 16 and its ability to bind to ACE2 of the GI tract has been identified.”
Coronavirus disease 2019 (COVID-19): current status and future perspectives (2020, background): “or indirect contact with mucous membranes in the eyes, mouth, or nose [37-39].”
Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence (2020, positive): “Moreover, SARS-CoV-2 was detected in the tears and conjunctival secretions of covid-19 patients [25] .”